Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice

This publication has 24 references indexed in Scilit:

• Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results
  Radiotherapy and Oncology, 2004
• Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584
  Seminars in Oncology, 2003
• Tumorigenesis and the angiogenic switch
  Nature Reviews Cancer, 2003
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
  Seminars in Oncology, 2002
• Inhibition of Growth and Metastasis of Human Pancreatic Cancer Growing in Nude Mice by PTK 787/ZK222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases
  Cancer Biotherapy & Radiopharmaceuticals, 2001
• No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamous cell carcinoma in nude mice
  Radiotherapy and Oncology, 2001
• Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse
  International Journal of Radiation Biology, 2001
• New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis
  Journal of Medicinal Chemistry, 2000
• Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
  Journal of Clinical Investigation, 1999